SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-023672
Filing Date
2024-02-14
Accepted
2024-02-14 16:16:35
Documents
1
Group Members
DR. SRINIVAS AKKARAJUSAMSARA BIOCAPITAL GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm245429d33_sc13g.htm SC 13G 81112
  Complete submission text file 0001104659-24-023672.txt   83026
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 24638506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

IRS No.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G